Fulcrum Therapeutics (NASDAQ: FULC) director files Form 3 with no shares owned
Rhea-AI Filing Summary
Fulcrum Therapeutics, Inc. director Joshua Lehrer-Graiwer filed an initial ownership report indicating that he currently holds no company securities. The filing shows zero shares directly owned following the reported holding entry, meaning he reports no beneficial ownership of Fulcrum Therapeutics stock at this time.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lehrer-Graiwer Joshua
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | No securities are beneficially owned | -- | -- | -- |
Holdings After Transaction:
No securities are beneficially owned — 0 shares (Direct)
Key Figures
Shares beneficially owned: 0 shares
1 metrics
Shares beneficially owned
0 shares
Total shares following holding entry on April 23, 2026
Key Terms
Form 3, beneficially owned, reporting person
3 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3)"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficially owned financial
"security_title: "No securities are beneficially owned""
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
reporting person regulatory
""reportingPersons": [ { "name": "Lehrer-Graiwer Joshua""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Fulcrum Therapeutics (FULC) Form 3 for Joshua Lehrer-Graiwer show?
The Form 3 shows that director Joshua Lehrer-Graiwer reports no beneficial ownership of Fulcrum Therapeutics, Inc. securities. The filing lists zero shares directly owned following the holding entry dated April 23, 2026, establishing his initial ownership baseline as a director.
Is the Fulcrum Therapeutics (FULC) Form 3 a buy or sell transaction?
The Form 3 for Joshua Lehrer-Graiwer does not report any buy or sell transactions. It is an initial ownership filing that records a holding entry with an unknown transaction code and confirms zero shares beneficially owned, establishing his starting position as a company director.
What is the significance of reporting zero beneficial ownership on a Form 3 for FULC?
Reporting zero beneficial ownership on a Form 3 means the insider currently holds no reportable Fulcrum Therapeutics, Inc. securities. It sets an official baseline for future Forms 4 or 5, so any later acquisitions, dispositions, or grants can be measured against today’s zero-share starting point.